4.6 Article

Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fcvm.2023.1210801

关键词

renal denervation (RDN); uncontrolled hypertension; renal function; ambulatory blood pressure; long-term effect

向作者/读者索取更多资源

In this study, long-term follow-up was conducted on patients who underwent renal sympathetic denervation therapy using radiofrequency. The results showed that renal sympathetic denervation can lead to long-term blood pressure reduction without negative effects on renal function.
BackgroundRenal sympathetic denervation (RDN) has been shown to lower arterial blood pressure both in the presence and in the absence of antihypertensive medication in an observation period of up to 3 years. However, long-term results beyond 3 years are scarcely reported. MethodsWe performed a long-term follow-up on patients who were previously enrolled in a local renal denervation registry and who underwent radiofrequency RDN with the Symplicity Flex & REG; renal denervation system between 2011 and 2014. The patients were assessed to evaluate their renal function by performing 24-hour ambulatory blood pressure measurement (ABPM), recording their medical history, and conducting laboratory tests. ResultsAmbulatory blood pressure readings for 24 h were available for 72 patients at long-term follow-up (FU) [9.3 years (IQR: 8.5-10.1)]. We found a significant reduction of ABP from 150.1/86.1 & PLUSMN; 16.9/12.0 mmHg at baseline to 138.3/77.1 & PLUSMN; 16.5/11.1 mmHg at long-term FU (P < 0.001 for both systolic and diastolic ABP). The number of antihypertensive medications used by the patients significantly decreased from 5.4 & PLUSMN; 1.5 at baseline to 4.8 & PLUSMN; 1.6 at long-term FU (P < 0.01). Renal function showed a significant but expected age-associated decrease in the eGFR from 87.8 (IQR: 81.0-100.0) to 72.5 (IQR: 55.8-86.8) ml/min/1.73 m(2) (P < 0.01) in patients with an initial eGFR > 60 ml/min/1.73 m(2), while a non-significant decrease was observed in patients with an initial eGFR < 60 ml/min/1.73 m(2) at long-term FU [56.0 (IQR: 40.9-58.4) vs. 39.0 (IQR: 13.5-56.3) ml/min/1.73 m(2)]. ConclusionsRDN was accompanied by a long-lasting reduction in blood pressure with a concomitant reduction in antihypertensive medication. No negative effects could be detected, especially with regard to renal function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据